DYR-747

N/A

Report date: 2025/01/26 16:27:11
NME

Base Information

Drug NameDYR-747
Drug Alias NameDYR-747
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionWingless type MMTV integration site family protein inhibitorsClk dual-specificity kinase inhibitorsDYRK kinase inhibitors +[4] 
TargetsDYRK kinaseDual specificity protein kinase CLKWingless type MMTV integration site family protein +[4] 
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Arizona
China Registration ClassN/A

Develop Information

Active CompaniesIluminos Therapeutics LLCThe University Of ArizonaUniversity Of Dundee
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A